
Kate Beattie KC
- Commercial Law Intellectual Property
- Public Law
Kate has a background in pharmacology and regularly acts for pharmaceutical and healthcare companies. She also advises on trade practices and commercial disputes, particularly those involving scientific expert evidence.
She holds a Bachelor of Science majoring in pharmacology and toxicology, a Bachelor of Laws (First Class Honours) from Monash University and a Master of Law (First Class Honours) from the University of Cambridge.
Before coming to Bar, Kate was a senior associate in the intellectual property department at Allens Arthur Robinson. She also practised at Freshfields Bruckhaus Deringer, London. Kate is an author of the text book, "Australian Patent Law" (2004). She has also been a sessional lecturer in contract law in the LLM (Juris Doctor) Program, Monash University.
Kate has been repeatedly recommended in Chambers and Partners. In 2023, she was described as having “significant experience in patent cases, particularly in the pharmaceutical field. Her work is of very high quality, and she is a pleasure to work with.”
Liability limited by a scheme approved under Professional Standards legislation.
Contact
- P+61 3 9225 6729
- M0413 610 315
- E[email protected]
- Connect on Linkedin
Emmerson Chambers
Room 3 Level 18
200 Queen Street
Melbourne VIC 3000
Jane King
+61 3 9225 8558
0414 251 921
Expertise
- Competition
- Consumer Law
- Contractual Disputes
- Appellate
- Copyright & Designs
- Patents
- Trade Marks
- Privacy
Qualifications
Master of Laws (First Class Hons)(Cambridge)
Bachelor of Laws (First Class Hons)(Monash)
Bachelor of Science (Pharmacology and Toxicology)
Victoria
State and Territory Courts and Tribunals
Federal Court of Australia
High Court of Australia
Recent Cases
- Sandoz AG v Bayer IP GmbH [2024] FCAFC 135 (acting for Bayer)
- Dyno Nobel Asia Pacific Pty Ltd v Orica Explosives Technology Pty Ltd - NSD 345/2022 (acting for Orica)
- Sanofi v Amgen Inc NSD 876/2022 (acting for Sanofi)
- Miele & Cie KG v Wilhelm Bruckbauer and another VID 711/2023 (acting for Miele)
- Perfect Day Inc v Commissioner of Patents [2025] FCA 270 (acting for the Commissioner of Patents)
- Commonwealth Scientific and Industrial Research Organisation v Urrbrae Foods Pty Ltd (2023) 174 IPR 377 (acting for CSIRO)
- CSIRO v BASF Plant Science GmbH [2020] FCA 328 (acting for CSIRO)
- Interpharma Pty Ltd v Hospira, Inc (No. 5) [2019] FCA 960 (acting for Hospira)
- GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Ltd [2018] FCAFC 71 (acting for Generic Partners)
- Janssen Sciences Ireland Unlimited Company v Juno Pharmaceutical NSD 698 of 2020
- CSIRO v BASF Plant Science GmbH [2020] FCA 328
- ESCO Australia Holding P/L v CQMS and Anor VID 63 of 2019
- Interpharma Pty Ltd v Hospira, Inc (No. 5) [2019] FCA 960
- GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Ltd [2018] FCAFC 71
- Daiwa Can Company v Barokes Pty Ltd [2016] VSC 296
- Paul Laurence Mizzi v Daryl Morellini [2015] APO 24 (patent opposition)
- Re Gunns Plantations Ltd [2014] VSC 369 (insolvency)
- Ranbaxy Laboratories Ltd v AstraZeneca AB (2013) 101 IPR 11 (pharmaceutical patent litigation)
- Vehicles Monitoring Systems Pty Ltd v Sarb Management Group Pty Ltd (2013) 101 IPR 496 (patent litigation)
- Spotless v Qantas Airways (2012) No VID 1183 of 2011 (trade mark and trade practices litigation)
- Albany Molecular Research Inc v Alphapharm Pty Ltd (2011) 90 IPR 457 (pharmaceutical patent litigation)
- Primary Health Care Limited v The Commissioner of Taxation of the Commonwealth of Australia (2010) 186 FCR 301 (tax, copyright)
- Vawdrey Australia Pty Ltd v Krueger Transport Equipment Pty Ltd (2009) 83 IPR 1 (copyright, confidential information)
- GlaxoSmithKline Australia Pty ltd v Jarrod Ritchie and TPI Enterprises Pty Ltd (2008) 77 IPR 306 (confidential information)
- Ranbaxy Australia Pty Ltd v Warner-Lambert Company LLC (2008) 77 IPR 449 (pharmaceutical patent litigation)